
Therapeutic Area | MeSH |
|---|---|
| mental disorders | D001523 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PROLIXIN | Bristol Myers Squibb | N-012145 DISCN | 1982-01-01 | 1 products, RLD |
| PROLIXIN | Bristol Myers Squibb | N-011751 DISCN | 1982-01-01 | 5 products |
| PERMITIL | Merck & Co | N-016008 DISCN | 1982-01-01 | 1 products |
| PERMITIL | Merck & Co | N-012419 DISCN | 1982-01-01 | 1 products |
| PERMITIL | Merck & Co | N-012034 DISCN | 1982-01-01 | 4 products |
Brand Name | Status | Last Update |
|---|---|---|
| fluphenazine decanoate | ANDA | 2025-11-07 |
| fluphenazine hydrochloride | ANDA | 2026-01-29 |
| fluphenazine hydrochoride | ANDA | 2025-10-08 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| schizophrenia | EFO_0000692 | D012559 | F20 |
| psychotic disorders | — | D011618 | F20.81 |
Code | Description |
|---|---|
| J2680 | Injection, fluphenazine decanoate, up to 25 mg |

| Drug common name | Fluphenazine |
| INN | fluphenazine |
| Description | Fluphenazine is a member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position. It has a role as a phenothiazine antipsychotic drug, a dopaminergic antagonist and an anticoronaviral agent. It is an organofluorine compound, a member of phenothiazines and a N-alkylpiperazine. It derives from a hydride of a 10H-phenothiazine. |
| Classification | Small molecule |
| Drug class | Typical antipsychotic |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 |
| PDB | — |
| CAS-ID | 69-23-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL726 |
| ChEBI ID | 5123 |
| PubChem CID | 3372 |
| DrugBank | DB00623 |
| UNII ID | S79426A41Z (ChemIDplus, GSRS) |






